Johnson & Johnson Reports Positive Phase 2/3 Resul...
Category : Clinical Trial Update 12 June 2026ENERGY Study Shows Significant Hemoglobin Improvement in Patients with Rare Blood Disorder Johnso...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Lateral Pharma Highlights New Therapeutic Target f...
Category : Clinical Trial Update 12 June 2026Study Published in PAIN Journal Identifies LanCL1 as a Potential Target for Chronic Nerve Pain Treat...
Novartis Reports Positive FORTITUDE Study Results...
Category : Clinical Trial Update 12 June 2026Biomarker Data Shows Strong Target Engagement and Reduced Muscle Damage Novartis has announced po...
Gilead and Merck Report Positive Phase 3 Results f...
Category : Clinical Trial Update 11 June 2026The way HIV is treated has changed dramatically over the last few decades. Daily antiretroviral ther...
Caliway Presents New Data on CBL-514 Combination T...
Category : Clinical Trial Update 11 June 2026Caliway Biopharmaceuticals has announced new preclinical data for its investigational drug candidate...
Latest Newsletter Post
-
Novartis Reports Positive FORTITUDE..
12 June 2026
-
Lateral Pharma Highlights New Thera..
12 June 2026
-
Johnson & Johnson Reports Positive..
12 June 2026
-
Elixiron Reports Positive Phase 2 I..
11 June 2026
-
Caliway Presents New Data on CBL-51..
11 June 2026
